Whipple surgeon

The Whipple procedure, also called a pancreaticoduodenectomy, removes the head of the pancreas along with the duodenum, the gallbladder and the distal bile duct. These structures are taken together because they share a blood supply and sit in the same anatomical space. Once the diseased tissue is out, the remaining pancreas, bile duct and stomach are reconnected to the small intestine so digestion can continue. It is one of the more complex abdominal operations, and it can be performed open or robotically depending on the tumour and the patient.

The Whipple is considered when a tumour in the head of the pancreas, the distal bile duct, the duodenum or the ampulla can be removed completely. Candidacy depends mainly on whether the tumour involves nearby blood vessels and whether the disease has spread beyond the pancreas. If imaging shows the cancer has spread to the liver, the lining of the abdomen or other distant sites, surgery is generally not recommended, because it does not improve survival in that situation. Some patients who are not candidates at first become candidates after chemotherapy shrinks the tumour. Determining this requires dedicated imaging and review by a multidisciplinary team.

Yes. The same operation treats several cancers that arise in the same region, collectively called periampullary cancers. These include cancer of the ampulla of Vater, the distal bile duct and the duodenum. Because these structures sit together anatomically, the surgical approach is the same even though the cancers behave differently and carry different outlooks. The Whipple is also occasionally used for non-cancerous conditions, including some pancreatic cysts and selected cases of chronic pancreatitis.

Both operations remove the same tissue and rebuild the same connections. The difference is access. An open Whipple is performed through a single larger abdominal incision. A robotic Whipple is performed through several small incisions using instruments the surgeon controls from a console, which allows magnified three-dimensional vision and finer instrument movement. Patients who have a robotic Whipple often leave hospital a little sooner and have less wound pain. Not every patient is suitable for the robotic approach. Tumour position, involvement of blood vessels, body habitus and previous abdominal surgery all affect the decision, and an operation that begins robotically may be converted to open if that is safer.

Most patients spend several days on the surgical ward, commonly three to five, and some need a short period in intensive care first. Patients who have the operation robotically often go home a little sooner than those who have open surgery. A follow-up appointment is usually arranged around a week after discharge. Returning to normal activity generally takes six to eight weeks, and appetite and energy often take longer than that to settle. Recovery varies considerably between patients, and your own expected timeline will be discussed with you before surgery.

The Whipple is a major operation and it carries real risk, which is why it should be done at a centre that performs it regularly. The most common specific complication is a pancreatic fistula, a leak from the join between the pancreas and the intestine, which sometimes needs a drain and a longer hospital stay. Other recognised complications include delayed gastric emptying, where the stomach is slow to resume working, bleeding, infection and blood clots. Longer term, some patients develop difficulty digesting fat and need pancreatic enzyme supplements, and some develop diabetes. These risks are discussed in detail during consultation, alongside the expected benefit in each individual case.

Most patients return to their usual activities, but there are lasting adjustments. Because part of the pancreas is removed, many patients need pancreatic enzyme capsules with meals to digest food properly, and some develop diabetes and need treatment for it. Smaller, more frequent meals are usually easier than large ones, particularly in the first few months. A dietitian is part of the care team for this reason. Many patients find that symptoms caused by the tumour, such as jaundice, pain or weight loss, improve after surgery.

Outlook depends heavily on the type of cancer, its stage and whether the tumour was removed completely. For pancreatic cancer of the head of the pancreas that is resectable, five-year survival is around 20 percent when surgery is followed by chemotherapy, and reaches 20 to 25 percent in high-volume centres. Without chemotherapy after surgery it is closer to 12 percent, which is why the two treatments are used together. Periampullary cancers of the ampulla and the distal bile duct generally carry a better outlook than pancreatic cancer. These are population figures and they cannot predict an individual outcome, which depends on the specifics of each case and is discussed at consultation.